The S&I (Sustain and Improve) lead is accountable for the delivery (project KPI and value add realization) of the IPT S&I project portfolio and landscape enterprise wide (except CMC+ and CAPEX projects managed by Project Delivery).

The incumbent will achieve this by:

• Acting as Sponsor, Project lead and/or Technical execution lead for individual S&I Projects & Programs (selecting acting project function based on identified need in the project and priority within the IPT, to assure successful delivery of the project KPIs and output)
• Managing complex interdependencies across all S&I projects in IPT
• Providing input into the business cases for prioritization of new projects
• Working with Tech Dev Lead and IPT Lead to manage resources on a day-to-day basis, addressing urgent needs as they arise (this includes the coordination with the IPT relevant MS&T lead(s), to prioritize and integrate potential operations initiatives and projects within the S&I project portfolio)
• Consolidating updates across S&I projects and providing integrated overview to the IPT lead
• Owning accountability for achieving and delivering KPIs across the entire S&I portfolio

In general the S&I role is a enterprise wide senior technical role operating with matrix leadership within the IPT. Based on S&I portfolio complexity and needs integrates project managers as direct reports to assure delivery of the S&I project portfolio

RESPONSIBILITIES AND ACCOUNTABILITIES

Lead a cross-functional product focused team (matrix) with the accountability to deliver the defined outcome (KPI and value add realization) of the IPT relevant S&I project portfolio. May manage S&I project managers directly to assure the delivery of S&I projects.

Accountable for the delivery of the S&I project portfolio, by

• Driving the projects through a direct key project role via sponsorship, direct project management and/or technical lead
• Establishing the S&I project KPIs, plus track and act (accountable for achievement)
• Assure S&I project value-add realization as defined in business case

Technical responsibility for S&I project portfolio maintenance and continuous improvement

• Assess and prioritize based on current business needs improvement/best practice opportunities for selected product (in exchange with partners in Operations and within the IPT, i.e. MS&T lead) and integrate in consultation with the IPT lead into the S&I project portfolio for consideration and select those opportunities that provide meaningful benefits to the company (business case driven) and patients.
• Work closely with the various manufacturing sites, IPT leadership team and global partners to identify and to bring continuous improvement and best practice to the relevant IPTs and integrate in the S&I project portfolio.
• Provide leadership and direction for the S&I portfolio of projects for the in-scope product, aligned within the IPT and with internal stakeholders like Network strategy, Operations Value Stream partners, Project delivery
• Manage interdependencies between IPT relevant S&I projects, i.e. by developing and owning a technical Product Roadmap for the portfolio of projects in scope
• Prepare and ensure business/financial drivers, especially for project portfolio prioritization are understood by the team and built into the Roadmap

Foster and manage successful relationships with senior executive stakeholders to manage expectations and achieve successful S&I project portfolio outcomes. Integration of the S&I project portfolio into the established governance process.

Review and approve global process changes, project stage gates (technical), tech transfers, and if required multi-site CAPAs in context of the S&I project portfolio

• Support the respective IPT lead with product performance health management and general product KPI definition and delivery
• Support the MS&T organization with enterprise-wide product technical expertise

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.